Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
IGF-1 DES and Acetic Acid Mix

IGF-1 DES Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

⚠ Use acetic acid — not bacteriostatic water IGF-1 DES is insoluble or unstable in standard BAC water. Manufacturer protocols require reconstitution in dilute acetic acid (0.1%) — or, for IGF-1 variants, 50 mM acetic acid. Volumes shown below refer to acetic acid, not water.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example IGF-1 DES Titration Schedule

ParameterDetails
Typical dose50 mcg per injection (40–60 start)
RouteIM into trained muscle, bilateral
TimingImmediately POST-workout
FrequencyTraining days only
Cycle4–6 weeks on / 4–6 off

Pre-workout administration wastes the peptide and raises hypoglycemia risk; post-workout leverages elevated blood flow and receptor upregulation. No human efficacy trials exist.

Possible vial strengths:

What Is It?

IGF-1 DES

Truncated IGF-1 (DES 1-3) variant.

Acetic Acid (0.1%)

A dilute solution of acetic acid (typically 0.1% for most peptides, or 50 mM for IGF-1 variants) used to reconstitute peptides that are insoluble or unstable in standard bacteriostatic water. IGF-1 DES requires an acidic carrier to dissolve fully and remain stable — plain BAC water will not work and may damage the peptide.

How To Mix IGF-1 DES

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw Acetic Acid

Draw the selected amount of 0.1% acetic acid.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

IGF-1 DES Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

IGF-1 DES usually refers to des(1-3)IGF-I, a shortened IGF-1 analog missing the first three amino acids at the N-terminus. That small structural deletion is the reason it is discussed separately from regular IGF-1 and IGF-1 LR3.
IGF-1 DES and IGF-1 LR3 are not two names for the same compound. DES is a truncated IGF-1 analog, while LR3 is a longer modified analog with an added N-terminal extension and an arginine substitution.
The phrase “IGF-1 DES half life 20–30 minutes” reflects a common search intent around short activity windows. A calculator can help with concentration and volume math, but it should not convert half-life searches into timing, injection, or protocol advice.
For calculator math, 1 mg equals 1,000 mcg. If a 1 mg vial is brought to 4 mL total volume, the concentration is 250 mcg/mL; on a U-100 syringe, 0.10 mL equals 10 units and contains 25 mcg. This is concentration math only, not a suggested amount.
IGF-1 DES discussions should start with IGF-pathway biology, including glucose-related effects, growth-factor signaling, and injection-site concerns in research contexts. “Before and after” or bodybuilding claims do not replace controlled safety data.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides